Advertisement

Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein

Rupali Das, Peng Guan, Susan J. Wiener, Nishant P. Patel, Trevor G. Gohl, Elizabeth Evans, Maurice Zauderer and Kim E. Nichols

Article Information

Citation 
vol. 3 no. 5 813-824
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted November 19, 2018
  • Accepted January 17, 2019
  • Published online March 11, 2019.


Contributors 
  • Rupali Das, 1Department of Physiology, Michigan State University, East Lansing, MI;
  • Peng Guan, 2Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA;
  • Susan J. Wiener, 2Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA;
  • Nishant P. Patel, 2Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA;
  • Trevor G. Gohl, 1Department of Physiology, Michigan State University, East Lansing, MI;
  • Elizabeth Evans, 3Vaccinex Inc., Rochester, NY; and
  • Maurice Zauderer, 3Vaccinex Inc., Rochester, NY; and
  • Kim E. Nichols, 4Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output